The physiology of erectile dysfunction

Herz

Volumn 28, Issue 4, 2003, Pages 277-283

  Russell, Shane ^b   Nehra, Ajay ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Anatomy; Cardiovascular disease; Erections; Physiology

Indexed keywords

CARDIOVASCULAR SYMPTOM; CORONARY RISK; ERECTILE DYSFUNCTION; HUMAN; MUSCULOSKELETAL SYSTEM; PENIS ERECTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; RISK FACTOR; VASOMOTOR DISORDER;

EID: 0038606542     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-003-2479-7     Document Type: Review

References (44)

1. Muller JE. Sexual activity as a trigger for cardiovascular events: what is the risk? Am J Cardiol 1999;84:2N-5N.
2. Anonymous. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993;270:83-90.
3. Kloner RA. Erectile dysfunction and cardiovascular risk factors. Hosp Pract (Off Ed) 2001;36:41-4,49-51.
4. Feldman HA, Goldstein I, Hatzichristou DG. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
5. Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction and priapism. In: Walsh PC, Retik AB et al., eds. Campbell's urology. Darien: Saunders, 1998:1155-74.
6. Abouseif SR, Tanagho EA, Anatomy of the penis. In: Hellstrom JG, ed. The handbook of sexual dysfunction. San Fransisco: Allen Press, 1999:2-6.
7. Saenz de Tejada I, Cavidad NG, Heaton J, et al. Anatomy, physiology and pathophysiology of erectile function. In: Jardin A, Wagner G et al., eds. Erectile dysfunction. United Kingdom: Health Publication, 2000:65-102.
8. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985;1:181-4.
9. Andersson K, Stief C. Penile erection and cardiac risk: pathophysiologic and pharmacologic mechanisms. Am J Cardiol 2000; 86:23F-6F.
10. Donatucci CF, Lue TF. Physiology of penile tumescence. In: Hashmat AI, Das S, eds. The penis. Philadelphia: Lea & Febiger, 1993: 17-22.
11. Kloner RA, Zusman RM. Cardiovascular effects of sildenafil citrate and recommendations for its use. Am J Cardiol 1999; 84:11N-7N.
12. Nehra A. Intracavernosal therapy: when oral agents fail. Curr Urol Rep 2001;2:468-72.
13. Rampin O, Giuliano F. Central control of the cardiovascular and erection systems: possible mechanisms and interactions. Am J Cardiol 2000;86:19F-22F.
14. Whitehead ED, Klyde BJ. Diabetes-related impotence in the elderly. Clin Geriatr Med 1990;6:771-95.
15. Chung WS, Shim BS, Park YY. Hemodynamic insult by vascular risk factors and pharmacologic erection in men with erectile dysfunction: Doppler sonography study. World J Urol 2000;18: 427-30.
16. Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989;320:1025-30.
17. Christ GJ, Stone B, Melman A. Age-dependent alterations in the efficacy of phenylephrine-induced contractions in vascular smooth muscle isolated from the corpus cavernosum of impotent men. Can J Physiol Pharmacol 1991;69:909-13.
18. Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000;30:328-38.
19. Azadzoi KM, Siroky MB, Goldstein I. Study of etiologic relationship of arterial atherosclerosis to corporal veno-occlusive dysfunction in the rabbit. J Urol 1996;155:1795-800.
20. Sullivan ME, Thompson CS, Dashwood MR, Khan MA, Jeremy JY, Morgan RJ, Mikhailidis DP. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999;43:658-65.
21. Sullivan ME, Dashwood MR, Thompson CS, Mikhailidis DP, Morgan RJ. Down-regulation of endothelin-B receptor sites in cavernosal tissue of hypercholesterolaemic rabbits. Br J Urol 1998;81:128-34.
22. Rosen MP, Greenfield AJ, Walker TG, Grant P, Dubrow J, Bettmann MA, Fried LE, Goldstein I. Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J Urol 1991;145:759-63.
23. Juenemann KP, Lue TF, Luo JA, Benowitz NL, Abozeid M, Tanagho EA. The effect of cigarette smoking on penile erection. J Urol 1987;138:438-41.
24. Xie Y, Garban H, Ng C, Rajfer J, Gonzalez-Cadavid NF. Effect of long-term passive smoking on erectile function and penile nitric oxide synthase in the rat. J Urol 1997;157:1121-6.
25. Jaffe A, Chen Y, Kisch ES, Fischel B, Alon M, Stern N. Erectile dysfunction in hypertensive subjects. Assessment of potential determinants. Hypertension 1996;28:859-62.
26. Hughes GS, Mathur RS, Margolius HS. Sex steroid hormones are altered in essential hypertension. J Hypertens 1989;7:181-7.
27. Khaw KT, Barrett-Connor E. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens 1988; 6:329-32.
28. Wein AJ, Van Arsdalen KN. Drug-induced male sexual dysfunction. Urol Clin North Am 1988;15:23-31.
29. Benet AE, Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am 1995;22:699-709.
30. Rosen RC, Kostis JB, Jekelis A, Taska LS.I. Sexual sequelae of antihypertensive drugs: treatment effects on self-report and physiological measures in middle-aged male hypertensives. Arch Sex Behav 1994;23:135-52.
31. Rosen RC, Kostis JB, Jekelis AW. Beta-blocker effects on sexual function in normal males. Arch Sex Behav 1988;17:241-55.
32. Rosen RC, Weiner DN. Cardiovascular disease and sleep-related erections [Comment]. J Psychosom Res 1997;42:517-30.
33. Weiss RJ. Effects of antihypertensive agents on sexual function. Am Fam Physician 1991;44:2075-82.
34. Srilatha B, Adaikan PG, Arulkumaran S, Ng SC. Sexual dysfunction related to antihypertensive agents: results from the animal model. Int J Impot Res 1999;11:107-13.
35. Anonymous. Drugs that cause sexual dysfunction: an update. Med Lett Drugs Ther 1992;34:73-8.
36. Mroczek WJ, Davidov M, Finnerty FA Jr. Prolonged treatment with clonidine: comparative antihypertensive effects alone and with a diuretic agent. Am J Cardiol 1972;30:536-41.
37. Bansal S. Sexual dysfunction in hypertensive men. A critical review of the literature. Hypertension 1988;12:1-10.
38. McCarron DA. Diuretic therapy for mild hypertension: the "real" cost of treatment. Am J Cardiol 1984;53:9A-11A.
39. Horowitz JD, Goble AJ. Drugs and impaired male sexual function. Drugs 1979;18:206-17.
40. Neri A, Aygen M, Zukerman Z, Bahary C. Subjective assessment of sexual dysfunction of patients on long-term administration of digoxin. Arch Sex Behav 1980;9:343-7.
41. Meinhardt W, Kropman RF, Vermei JP, Nijeholt AA, Zwartendijk J. The influence of medication on erectile function. Int J Impot Res 1997;9:17-26.
42. DeBusk R, Drory Y, Goldstein I, Jackson G, Kaul S, Kimmel SE, Kostis JB, Kloner RA, Lakin M, Meston CM, Mittleman M, Muller JE, Padma-Nathan H, Rosen RC, Stein RA, Zusman R. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000;86:62F-8F.
43. Bruckert E, Giral P, Heshmati HM, Turpin G. Men treated with hypolipidaemic drugs complain more frequently of erectile dysfunction. J Clin Pharm Ther 1996;21:89-94.
44. Kostis JB, Rosen RC, Wilson AC. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia. J Clin Pharmacol 1994;34:989-96.